Suraksha Diagnostic Peer Comparison

Suraksha Diagnostic Ltd. exhibits moderate growth and profitability metrics but faces challenges with valuation compared to peers. While it shows effective cash flow management, its high PE ratio indicates it may be overvalued relative to peers. Companies like Narayana Hrudayalaya and Aster DM Healthcare show potential for value due to their low PE and high ROE, while others like Fortis Healthcare and Max Healthcare Institute appear financially weak with high debt levels and low margins.

• • Suraksha Diagnostic has a moderate revenue growth of 4.14% over 3 years but shows no YoY growth.
• • ROE and ROCE are decent at 15.93% and 24.92%, respectively, indicating good efficiency.
• • The PE ratio of 46.19 suggests it may be overvalued compared to peers with lower ratios and higher returns.
• • Aster DM Healthcare is a standout value pick with a low PE of 5.05 and reasonable profitability metrics.

• • Narayana Hrudayalaya Ltd.: Best ROE at 24.27% and low PE of 84.56, indicating solid profitability and reasonable valuation.
• • Aster DM Healthcare Ltd.: Lowest PE ratio of 5.05 and strong cash flow metrics, indicating high value relative to profitability.
• • Apollo Hospitals Enterprise Ltd.: High EPS growth and decent ROE of 20.51%, but with a high PE suggesting it may be overvalued.